Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background/Aims: To investigate the use of measurements of liver stiffness (LS) by two-dimensional real-time shear wave elastography (SWE) for predicting the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Methods: We retrospectively collected data on 291 enrolled patients with CHB whose LS had been measured using SWE. Results: The mean age of the patients was 46.8 years; males predominated (67%), and 40 of the patients (14%) had clinical cirrhosis. Among the patients, 165 (56.7%) received antiviral treatment. The median LS value was 7.4 kPa, and the median follow-up period was 35.8 months (range, 3.0 to 52.8 months). During follow-up, HCC developed in 13 patients (4.5%), and the cumulative incidence rates of HCC at 1, 2, and 4 years were 1.1%, 3.6%, and 8.4%, respectively. Based on a multivariate analysis, older age (≥50 years) and higher LS value (≥10 kPa) were independently associated with the risk of developing HCC (hazard ratio [HR], 4.53, p=0.023; and HR, 4.08, p=0.022). The cumulative incidence rate of HCC was significantly higher in patients with higher LS values (≥10 kPa) than in those with lower LS values (<10 kPa) (p=0.001). Conclusions: Increased LS measured by SWE at any time point regardless of antiviral treatment is associated with an increased risk of HCC in patients with CHB.
Abstract
Background/Aims: To investigate the use of measurements of liver stiffness (LS) by two-dimensional real-time shear wave elastography (SWE) for predicting the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Methods: We retrospectively collected data on 291 enrolled patients with CHB whose LS had been measured using SWE. Results: The mean age of the patients was 46.8 years; males predominated (67%), and 40 of the patients (14%) had clinical cirrhosis. Among the patients, 165 (56.7%) received antiviral treatment. The median LS value was 7.4 kPa, and the median follow-up period was 35.8 months (range, 3.0 to 52.8 months). During follow-up, HCC developed in 13 patients (4.5%), and the cumulative incidence rates of HCC at 1, 2, and 4 years were 1.1%, 3.6%, and 8.4%, respectively. Based on a multivariate analysis, older age (≥50 years) and higher LS value (≥10 kPa) were independently associated with the risk of developing HCC (hazard ratio [HR], 4.53, p=0.023; and HR, 4.08, p=0.022). The cumulative incidence rate of HCC was significantly higher in patients with higher LS values (≥10 kPa) than in those with lower LS values (<10 kPa) (p=0.001). Conclusions: Increased LS measured by SWE at any time point regardless of antiviral treatment is associated with an increased risk of HCC in patients with CHB.
참고문헌 (30)
- Schweitzer A, "Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013", Lancet, 386, pp.1546~1555 (2015)
- Wong VW, "Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection", J Hepatol, 63, pp.722~732 (2015)
- Dienstag JL, "The role of liver biopsy in chronic hepatitis C", epatology, 36(5 Suppl 1), pp.S152~S160 (2002)
- Bravo AA, "Liver biopsy", N Engl J Med, 344, pp.495~500 (2001)
- Bedossa P, "Sampling variability of liver fibrosis in chronic hepatitis C", Hepatology, 38, pp.1449~1457 (2003)
- Yoshioka K, "Can non-invasive assessment of liver fibrosis replace liver biopsy", Hepatol Res, 42, pp.233~240 (2012)
- Friedrich-Rust M, "Performance of transient elastography for the staging of liver fibrosis: a meta-analysis", astroenterology, 134, pp.960~974 (2008)
- Robic MA, "Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study", J Hepatol, 55, pp.1017~1024 (2011)
- Pang JX, "Liver stiffness by transient elastography predicts liver-related complications and mortality in patients with chronic liver disease", PLoS One, 9, pp.e95776~ (2014)
- Fung J, "Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B", J Viral Hepat, 18, pp.738~744 (2011)
- Jung KS, "Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)", Hepatology, 53, pp.885~894 (2011)
- Kim MN, "Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis", Hepatology, 61, pp.1851~1859 (2015)
- Friedrich-Rust M, "Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis", J Viral Hepat, 19, pp.e212~e219 (2012)
- Ferraioli G, "Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study", Hepatology, 56, pp.2125~2133 (2012)
- Singh S, "Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data", Clin Gastroenterol Hepatol, 13, pp.440~451.e6 (2015)
- Piscaglia F, "The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives", Eur J Radiol, 83, pp.450~455 (2014)
- Deffieux T, "Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography", J Hepatol, 62, pp.317~324 (2015)
- Leung VY, "Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation", Radiology, 269, pp.910~918 (2013)
- Korean Association for the Study of the Liver, "KASL clinical practice guidelines: management of chronic hepatitis B", Clin Mol Hepatol, 22, pp.18~75 (2016)
- Bruix J, "American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update", epatology, 53, pp.1020~1022 (2011)
- Xu X, "Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test", Hepatol Int, 9, pp.558~566 (2015)
- Wong GL, "Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B", J Hepatol, 60, pp.339~345 (2014)
- 정우경, "Principles and clinical application of ultrasound elastography for diffuse liver disease", ULTRASONOGRAPHY, 33(3), pp.149~160 (2014), 대한초음파의학회
- 이홍섭, "Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis", Clinical and Molecular Hepatology, 16(4), pp.369~375 (2010), 대한간학회
- Zeng J, "Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation", Eur Radiol, 24, pp.2572~2581 (2014)
- Chen CJ, "Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level", JAMA, 295, pp.65~73 (2006)
- Chang TT, "Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B", Hepatology, 51, pp.422~430 (2010)
- Marcellin P, "Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study", Lancet, 381, pp.468~475 (2013)
- Lee HW, "Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy", Am J Gastroenterol, 109, pp.1241~1249 (2014)
- Lampertico P, "The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: a 12-year prospective cohort study", J Hepatol, 63, pp.1118~1125 (2015)